Quarterly results
2018 Second Quarter and R&D update
We announced our second quarter 2018 results on Wednesday 25 July and hosted an investor event where Emma Walmsley, CEO, and Simon Dingemans, CFO, spoke about our performance and financial outlook, and Hal Barron, Chief Scientific Officer and President, R&D, presented our R&D update.
Highlights
Downloads
- Q2 2018 results and R&D update announcement PDF - 1.0MB
- Q2 2018 slides - Emma Walmsley PDF - 495.7KB
- Q2 2018 slides - Simon Dingemans PDF - 131.7KB
- R&D update slides - Hal Barron PDF - 1.9MB
- Q2 2018 results transcript - Part 1 PDF - 188.4KB
- Q2 2018 results transcript - Part 2 PDF - 242.3KB
- Q2 2018 results infographic PDF - 556.7KB
- Q2 2018 US dollar translation PDF - 131.6KB
- Q2 2018 pre announcement aide memoire PDF - 742.2KB
-
2015 Fourth Quarter
Watch Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our full year 2015 results. Watch Patrick Vallance, President, Pharmaceuticals R&D, give an update on R&D in 2015.
Related downloads
-
2015 Third Quarter
Watch Simon Dingemans, CFO, discuss our third quarter results 2015.
-
2015 Second Quarter
Watch Simon Dingemans, CFO, discuss our second quarter results 2015.
-
2015 First Quarter and prospects for newly shaped Group
Watch Simon Dingemans, CFO, discuss our first quarter results 2015.
Other key information
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Press releases
Keep up to date with our news and recent announcements
-
Product pipeline
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III
